论文部分内容阅读
目的:探讨血府逐瘀汤加减联合美施康定对气虚血瘀型中晚期癌症癌性疼痛的镇痛效果。方法:选取66例气虚血瘀型中晚期癌症癌性疼痛患者作为研究对象,按随机数字表法分为对照组和研究组各33例,对照组患者采取美施康定药物进行治疗,研究组患者在此基础上联合血府逐瘀汤进行治疗,比较两组患者的止痛效果。结果:经过治疗,研究组患者总有效率(48.48%)明显高于对照组(21.21%),其止痛效果明显优于对照组,差异具有统计意义(P<0.05)。结论:血府逐瘀汤加减联合美施康定对气虚血瘀型中晚期癌症癌性疼痛的镇痛效果显著,可明显降低患者的疼痛程度,对其生活质量的改善有着积极的意义,具有良好的临床应用价值。
Objective: To investigate the analgesic effects of Xuefu Zhuyu Decoction combined with Meishenkangding on mid-advanced cancer cancerous pain in qi deficiency and blood stasis type. Methods: Sixty-six cases of advanced cancer cancerous pain with Qi-deficiency and blood-stasis syndrome were selected as the research object. According to the random number table, the patients were divided into control group and study group, 33 cases each. Patients in the control group were treated with Meishi Kangding drug. On this basis, Xuefuzhuyu Decoction was used for treatment and the analgesic effect was compared between the two groups. Results: After treatment, the total effective rate (48.48%) in the study group was significantly higher than that in the control group (21.21%). The analgesic effect was significantly better than that in the control group (P <0.05). Conclusion: The combination of Xuefu Zhuyu Decoction combined with Meishen Kangding qi deficiency and blood stasis type of cancer pain in the late analgesic effect was significant, can significantly reduce the degree of pain in patients with improved quality of life has a positive meaning, with good The clinical value.